253 related articles for article (PubMed ID: 28426929)
21. Development of anti-HER2 fragment antibody conjugated to iron oxide nanoparticles for in vivo HER2-targeted photoacoustic tumor imaging.
Kanazaki K; Sano K; Makino A; Shimizu Y; Yamauchi F; Ogawa S; Ding N; Yano T; Temma T; Ono M; Saji H
Nanomedicine; 2015 Nov; 11(8):2051-60. PubMed ID: 26238078
[TBL] [Abstract][Full Text] [Related]
22. Imaging Tumor Necrosis with Ferumoxytol.
Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
[TBL] [Abstract][Full Text] [Related]
23. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
[TBL] [Abstract][Full Text] [Related]
24. Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.
England CG; Im HJ; Feng L; Chen F; Graves SA; Hernandez R; Orbay H; Xu C; Cho SY; Nickles RJ; Liu Z; Lee DS; Cai W
Biomaterials; 2016 Sep; 100():101-9. PubMed ID: 27254470
[TBL] [Abstract][Full Text] [Related]
25. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
26. Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI.
Chen TJ; Cheng TH; Chen CY; Hsu SC; Cheng TL; Liu GC; Wang YM
J Biol Inorg Chem; 2009 Feb; 14(2):253-60. PubMed ID: 18975017
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
[TBL] [Abstract][Full Text] [Related]
28. Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging.
Jeon SL; Chae MK; Jang EJ; Lee C
Chemistry; 2013 Mar; 19(13):4217-22. PubMed ID: 23345158
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-Responsive T
Lu Z; Yan J; Zu G; Xu M; Liu J; Zhang Y; Shi L; Fei X; Cao Y; Pei R
Bioconjug Chem; 2023 Sep; 34(9):1622-1632. PubMed ID: 37584604
[TBL] [Abstract][Full Text] [Related]
30. Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent.
Semkina AS; Abakumov MA; Grinenko NF; Lipengolts AA; Nukolova NV; Chekhonin VP
Bull Exp Biol Med; 2017 Apr; 162(6):808-811. PubMed ID: 28429228
[TBL] [Abstract][Full Text] [Related]
31. Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects.
Yang L; Zhou Z; Liu H; Wu C; Zhang H; Huang G; Ai H; Gao J
Nanoscale; 2015 Apr; 7(15):6843-50. PubMed ID: 25806860
[TBL] [Abstract][Full Text] [Related]
32. Controlling RNA Expression in Cancer Using Iron Oxide Nanoparticles Detectable by MRI and In Vivo Optical Imaging.
Medarova Z; Balcioglu M; Yigit MV
Methods Mol Biol; 2016; 1372():163-79. PubMed ID: 26530923
[TBL] [Abstract][Full Text] [Related]
33. Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
Satpathy M; Wang L; Zielinski RJ; Qian W; Wang YA; Mohs AM; Kairdolf BA; Ji X; Capala J; Lipowska M; Nie S; Mao H; Yang L
Theranostics; 2019; 9(3):778-795. PubMed ID: 30809308
[TBL] [Abstract][Full Text] [Related]
34. Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting.
Huang J; Wang L; Lin R; Wang AY; Yang L; Kuang M; Qian W; Mao H
ACS Appl Mater Interfaces; 2013 Jun; 5(11):4632-9. PubMed ID: 23633522
[TBL] [Abstract][Full Text] [Related]
35. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
36. J-aggregates of organic dye molecules complexed with iron oxide nanoparticles for imaging-guided photothermal therapy under 915-nm light.
Song X; Gong H; Liu T; Cheng L; Wang C; Sun X; Liang C; Liu Z
Small; 2014 Nov; 10(21):4362-70. PubMed ID: 24976309
[TBL] [Abstract][Full Text] [Related]
37. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
38. [2-deoxy-D-glucose modified supermagnetic iron oxide nanoparticles enhance the contrasting effect on MRI of human lung adenocarcinoma A549 tumor in nude mice].
Shan X; Yuan D; Xiong F; Gu N; Wang P
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):85-91. PubMed ID: 24796454
[TBL] [Abstract][Full Text] [Related]
39. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
Kuo YT; Chen CY; Liu GC; Wang YM
PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
[TBL] [Abstract][Full Text] [Related]
40. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
